BUSINESS

Iridex Reports First Quarter 2026 Loss, Mixed Results

▪

Read, Watch or Listen

Media Bias Meter

Sources: 6

Center 100%

Sources: 6

Mountain View, California — On May 19, 2026, Iridex Corporation reported a $524,000 net loss for the first quarter ended April 4, 2026, and revenue of $11.8 million. The Mountain View-based medical laser manufacturer disclosed a loss of three cents per share and released its quarterly figures this week. Company filings show gross profit of $4.7 million and a 40% gross margin, down from $5.0 million and 43% a year earlier, and operating expenses of $5.1 million. Management attributed margin pressure to higher manufacturing costs and tariff developments and noted an ongoing transition to lower-cost contract manufacturers as part of cost-savings efforts.

Prepared by Christopher Adams and reviewed by editorial team.

Timeline of Events

Quarter ended April 4, 2026: operational period for Q1 reporting.
May 19, 2026: Iridex issued Q1 2026 financial results via GlobeNewswire.
May 19, 2026: Benzinga and AP-distributing outlets published the Q1 results.
Company cited higher manufacturing costs and tariff impacts as drivers of margin decline.
Company confirmed continued transition to lower-cost contract manufacturers and noted modest operating expense reductions.

Why This Matters to You

Iridex's financial health can impact the cost of medical lasers, potentially affecting healthcare costs. If you're in the medical field, keep an eye on how this plays out. For investors, it's a reminder to watch for tariff impacts and manufacturing costs in your portfolio companies.

The Bottom Line

Iridex is feeling the pinch from higher manufacturing costs and tariffs, but they're fighting back with cost-saving measures. It's a tough time, but they're not down for the count. If you know someone invested in healthcare or manufacturing, they might appreciate this update.